InsidersTradesSigma
Cyteir Therapeutics, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Cyteir Therapeutics, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Cyteir Therapeutics, Inc. has logged 48 reports. The latest transaction was disclosed on 25 March 2024 (Acquisition). Among the most active insiders: Zakrzewski Joseph S. All data is openly available.
48
Insider Decl.
0
Thresholds
€957,222
12 ops.
Buy Volume
€3m
8 ops.
Sell Volume
27Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 25 March 2024
Declarations48 total
170,589 shares@ US$2.9559.5% of flowCommon Stock, par value $0.001 per shareSEC:0001373604-24-000010:0
Ideal exit: 15 Dec 2024 (T+270)
113,777 shares@ US$3.0140.5% of flowCommon Stock, par value $0.001 per shareSEC:0001373604-24-000006:0
Ideal exit: 13 Dec 2024 (T+270)
3,239 shares@ US$1.684.9% of flowCommon StockSEC:0001209191-24-004439:0
12,607 shares@ US$1.698.6% of flowCommon StockSEC:0001209191-24-004438:0
14,150 shares@ US$1.69100.0% of flowCommon StockSEC:0001209191-24-003437:0
12,129 shares@ US$1.69100.0% of flowCommon StockSEC:0001209191-24-003348:0
12,828 shares@ US$1.6951.4% of flowCommon StockSEC:0001209191-24-003090:0
14,150 shares@ US$1.6912.2% of flowCommon StockSEC:0001209191-24-002992:0
6,304 shares@ US$1.694.3% of flowCommon StockSEC:0001209191-23-058609:0
1,620 shares@ US$1.682.5% of flowCommon StockSEC:0001209191-23-058610:0
56,737 shares@ US$1.6938.7% of flowCommon StockSEC:0001209191-23-056426:0
52,584 shares@ US$1.6879.8% of flowCommon StockSEC:0001209191-23-056425:0
1,900 shares@ US$2.76160.1% of flowCommon StockSEC:0001209191-23-042977:0
11,000 shares@ US$2.73650.8% of flowCommon StockSEC:0001209191-23-042670:0
200,937 shares@ US$2.634115.2% of flowCommon StockSEC:0001209191-23-040691:0
8,437 shares@ US$1.79050.4% of flowCommon StockSEC:0001209191-23-040129:0
4,834 shares@ US$1.99440.3% of flowCommon StockSEC:0001209191-23-039545:0
10,002 shares@ US$2.030.6% of flowCommon StockSEC:0001209191-23-038567:0
900 shares@ US$2.06450.1% of flowCommon StockSEC:0001209191-23-037208:0
4,100 shares@ US$1.686.0% of flowCommon StockSEC:0001209191-23-007528:0
5,000 shares@ US$1.493.0% of flowCommon StockSEC:0001209191-23-007494:0
5,000 shares@ US$1.496.8% of flowCommon StockSEC:0001209191-23-007536:0
106,345 shares@ US$1.0345.4% of flowCommon StockSEC:0001209191-22-062627:0
21,202 shares@ US$1.3014.4% of flowCommon StockSEC:0001209191-22-060377:0
Ideal exit: 3 Sept 2023 (T+270)
900,000 shares@ US$3.0082.5% of flowCOMMON STOCKSEC:0001209191-22-043049:0
25 of 48 declarations
